Dr Stefan Oschmann Member of the Executive Board and Chief Executive Officer Pharma, Merck KGaA, Darmstadt, Germany, and President of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Inaugural speech-transcript Global health conference “Investing for Healthier Societies: Innovation, Inclusiveness and Sustainability” that the IFPMA is hosting in partnership with Devex (4 November 2014, New...
Read moreDr John C. Lechleiter Chairman, President, and Chief Executive Officer Eli Lilly and Company and IFPMA President Farewell Remarks Global health conference “Investing for Healthier Societies: Innovation, Inclusiveness and Sustainability” that the IFPMA is hosting in partnership with Devex (4 November 2014, New York) (www.ifpmaassembly2014.org). Thank you, Eduardo, and good afternoon, everyone. It’s a pleasure...
Read more• PAHO (Pan American Health Organization) Foundation and International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) combine efforts to improve breast and cervical cancer prevention and control. • The partnership aims to improve understanding and practices among primary health care providers and patients for breast cancer screening and early detection as well as increase capacity...
Read moreThais want a happy family life and to be healthy, but find it challenging to change behavior. 1 October 2014, Bangkok – The Health Systems Research Institute (HSRI), The Pharmaceutical Research and Manufacturers Association (PReMA), The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and Japan Pharmaceutical Manufacturers Association (JPMA) released a joint report...
Read moreIFPMA calls for action for collaborative approach to raise awareness on Hepatitis. Hepatitis is the world’s 8th biggest killer. The yearly death toll is equivalent to the number of people living in cities like Philadelphia or Barcelona. A comprehensive care model is needed, including research, prevention, screening, and care. On the occasion of World Hepatitis...
Read moreIFPMA is profoundly saddened at the news of the Malaysian Airlines crash. We extend our condolences to the families of those who lost their lives. We join the global health community in mourning the loss of scientists, researchers, health officials and campaigners and extend our deepest sympathy to all those colleagues, friends and fellow members...
Read moreUnited Nations NCD Review – Roundtable 2: “Fostering and strengthening national, regional and international partnerships and cooperation in support of efforts to address non-communicable diseases – NCDs” Intervention by Mario Ottiglio, Director, Public Affairs & Global Health Policy, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) New York, 11 July 2014 It is an honor...
Read moreGeneva, 6 June 2014 — Following the campaign’s six-month anniversary, Fight the Fakes is proud to announce eleven new partners, bringing the total number of member organizations to twenty-five. New partners, representing wholesalers, pharmacists, mobile app services, coalitions for consumer protection and generic pharmaceutical manufacturers, join the campaign to speak up and spread the word...
Read moreIFPMA Statement, WHA 67, Item 16.5, Combating antimicrobial resistance, including antibiotic resistance Delivered by Mr Mario Ottiglio, Director, Global Health Policy & Public Affairs, on 24 May 2014 Thank you for the opportunity to contribute to this important discussion today. IFPMA represents leading research-based pharmaceutical companies as well as national and regional industry associations across...
Read moreDelivered by Janis Bernat, Associate Director, Biotherapeutics and Scientific Affairs Check against delivery 15.6 Regulatory system strengthening (resolution EB134.R19) Access to biotherapeutic products and ensuring quality, safety and efficacy Thank you for the opportunity to provide input to this important discussion. The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) represents the leading research-based pharmaceutical...
Read moreDelivered by Mario Ottiglio, Director, Public Affairs & Global Health Policy Check against delivery – Item 13.3 Prevention and Control of Non Communicable Diseases NCD Global Coordination Mechanism Thank you for the opportunity to contribute to this important discussion today. IFPMA represents leading research-based pharmaceutical companies as well as national and regional industry associations across...
Read moreDelivered by Mario Ottiglio, Director, Public Affairs & Global Health Policy Check against delivery – Item 11.3, Framework of engagement with non-State actors Thank you for the opportunity to contribute to this important discussion today. IFPMA represents leading research-based pharmaceutical companies as well as national and regional industry associations across the world. IFPMA welcomes efforts...
Read more